Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Koulouris N, Gogos C, Koutsoukou A. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host & Microbe. [Internet] 2020 [citado 16/9/2020]; 27(6):992-1000. Disponible en: https://doi.org/10.1016/j.chom.2020.04.009.

Hunter, C.A.; Jones, S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. [Internet] 2015 [citado 16/9/2020];16(6):448–457. Disponible en: https://doi.org/10.1038/ni.3153

Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease (COVID-19)- induced cytokine release syndrome (CRS)? J Autoimmun. [Internet] 2020 [citado 16/9/2020];111: 102452. Disponible en: https://doi.org/10.1016/j.jaut.2020.102452

Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of severe COVID-19 patients with tocilizumab. ChinaXiv. [Internet] 2020 [citado 16/9/2020]; 202003 (00026): v1. Disponible en: https://doi.org/10.12074/202003.00026

Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory síndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. [Internet] 2020 [citado 16/9/2020]; 19(7): 102568. Disponible en: https://doi.org/10.1016/j.autrev.2020.102568

Lan SH, Lai CC, Huang HT, Chang SP, Lu LC, Hsueh PR. Tocilizumab for severe COVID-19: a systematic Review and meta-analysis. Int J Antimicrob Agents. [Internet]. 2020 [citado 16/9/2020]; 56(3): 106103. Disponible en: https://doi.org/10.1016/j.ijantimicag.2020.106103

Loganathan S, Athalye SN, Joshi S. Itolizumab, an anti-CD6 monoclonal antibody, as potential treatment for COVID-19 complications. Expert Opinion Biol Therap. [Internet]. 2020 [citado 16/9/2020]; 20(9): 1025-1031. Disponible en: https://doi.org/10.1080/14712598.2020.1798399

Saavedra D, Añe-Kourí AL, Sánchez N, Filgueira LM, Betancourt J, Herrera C, et al. An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe Covid-19 elderly patients. [Internet] [citado 16/9/2020], PREPRINT (versión 2). Disponible en Research Square: https://doi.org/10.21203/rs.3.rs-32335/v1

Diaz Y, Ramos-Suzarte M, Martin Y, Calderón NA, Santiago W, Viñet O, et al. Use of a humanized anti-CD6 monoclonal antibody in elderly patients with moderate COVID-19. medRxiv [Internet]. 2020 [citado 16/9/2020]. Disponible en: https://doi.org/10.1101/2020.07.24.20153833

Cuba. Ministerio de Salud Pública. Protocolo de Actuación Nacional para la COVID-19. Versión 1.4 [Internet]. La Habana: MINSAP; 2020 [citado 16/9/2020]. Disponible en: https://files.sld.cu/editorhome/files/2020/05/MINSAP_Protocolo-de-Actuaci%c3%b3n-Nacional-para-la-COVID-19_versi%c3%b3n-1.4_mayo-2020.pdf